Tissue engineered venous matrices for potential applications in the urogenital tract.
Tissue engineering is lacking inexpensive, easily applicable techniques for tissue replacement. We investigated the potential use of native veins for tissue-engineering applications in the urological field. Forty-eight porcine veins, half seeded with urothelial cells and half unseeded, were kept in vitro for 7 days. Four seeded and four unseeded scaffolds were analyzed after 3 and 7 days. The remaining 32 veins were implanted subcutaneously into 16 athymic mice. Four athymic mice were sacrificed after 2, 4, 8, and 12 weeks. Histochemistry, immunohistochemistry (anti-pancytokeratin AE1/AE3, anti-desmin), western blot analyses (CD31), and scanning electron microscopy were performed in the retrieved specimens. The histochemistry of the seeded matrices showed the presence of urothelial cells in vitro and in vivo. After 12 weeks, a multilayer of urothelial cells was present in the hemotoxylin and eosin staining, positive for anti-pancytokeratin AE1/AE3. The western blot analyses showed vascularization of the veins in vivo. The results of scanning electron microscopy revealed a cellular layer on the veins. Native venous matrices may be used as tissue-engineered constructs for reconstructing the urinary tract. The clinical relevance of this approach must be proven in a large-animal model.
Brito-Juarez
Marco
M
Department of Urology, University of Ulm, Ulm, Germany. georg.bartsch@uniklinik-ulm.de
Volkmer
Bjoern G
BG
Gschwend
Juergen E
JE
Hautmann
Richard E
RE
Bartsch
Georg C
GC
D000818:Animals; D002478:Cells, Cultured; D005240:Feasibility Studies; D051379:Mice; D008819:Mice, Nude; D013552:Swine; D023822:Tissue Engineering / Q000379:methods*; D019459:Urothelium / Q000166:cytology* / Q000637:transplantation*; D014682:Vena Cava, Inferior / Q000166:cytology* / Q000637:transplantation*